Surgeons Slowed Use of Pelvic Mesh Following FDA Warning, N.Y. Study Shows
This article was originally published in The Gray Sheet
Executive Summary
Use of surgical mesh for pelvic organ prolapse procedures in New York state declined following a 2011 FDA warning, according to a new study.
You may also be interested in...
TOPAS Fecal Incontinence Device Gets Unanimous Support For Approval At FDA Panel
All members of the agency's Gastroenterology and Urology Devices Panel were convinced by Astora Women’s Health's evidence in support of PMA approval for the TOPAS mesh implant device for fecal incontinence.
Regulatory News In Brief
Transvaginal surgical mesh scrutiny
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.